Business COVID-19 treatment: How Gilead's licensing agreement for remdesivir will progress Updated : May 13, 2020 11:14 PM IST This is the second voluntary license agreement that Gilead has signed. The earlier instance was in 2014-2015 for Gilead’s antiviral drug Sofosbuvir for treatment of Hepatitis C Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.